Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-end equity mutual fund with a primary focus on long-term capital appreciation through investments in the life sciences sector. Managed by abrdn Inc., the fund seeks opportunities in both U.S. and global markets, allocating capital predominantly to companies engaged in biotechnology, pharmaceuticals, diagnostics, healthcare information technology, managed healthcare, medical equipment, and related industries. Its portfolio strategy emphasizes growth-oriented stocks, often including small-cap firms with the potential for above-average expansion in revenues and earnings. The fund's investments are selected based on a rigorous fundamental analysis considering factors such as market position, management expertise, technological innovation, and financial sustainability. Abrdn Life Sciences Investors benchmarks its performance against key industry indices, including the NASDAQ Biotech Index and the S&P 500 Index. Demonstrating significant market stature, the fund typically holds a concentrated portfolio of leading life science companies and maintains allocations in venture capital and cash for diversification and liquidity management. Established in 1992, it plays an influential role in channeling capital to the innovation-driven life sciences industry, supporting advancements in healthcare and biotechnology.